| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 05/15/2003 | WO2003039549A2 Selective antibacterial agents |
| 05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
| 05/15/2003 | US20030092685 Administering a (bi- or tri)phenol compound containing a nitrogen ring |
| 05/15/2003 | US20030092576 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoyl-cyclohexenone derivatives; fungicides; bactericides; pesticides; crop protection; pre- and postemergence herbicides |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2465189A1 Substituted diphenyl heterocycles useful for treating hcv infection |
| 05/15/2003 | CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 05/15/2003 | CA2464757A1 Selective antibacterial agents |
| 05/14/2003 | EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 05/13/2003 | US6562965 Convergent synthesis of α-aryl-β-ketonitriles |
| 05/13/2003 | US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 05/13/2003 | US6562817 Suppressants of the IgE production |
| 05/08/2003 | WO2003037853A1 Substituted thioacetamides |
| 05/08/2003 | CA2462206A1 Substituted thioacetamides |
| 05/07/2003 | EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/07/2003 | EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity |
| 05/06/2003 | US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound. |
| 05/06/2003 | US6559100 2-benzoyl-cyclohexane-1,3-diones |
| 05/02/2003 | EP1306368A2 3,4-dihydro-1H-naphtalene derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 05/02/2003 | EP0966452B1 Process for preparing sulphurous 2-chloro-3-(4,5-dihydroisoxazol-3-yl)-benzoic acids |
| 05/02/2003 | EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 05/01/2003 | WO2003035602A1 Lipid modulators |
| 05/01/2003 | WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 05/01/2003 | US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science |
| 04/30/2003 | CN1107058C Subsitituted isoxazoles for treatment of inflammation |
| 04/29/2003 | US6555537 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032908A2 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 04/24/2003 | WO2002102376A8 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | US20030078266 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078239 Ketone compounds and compositions for cholesterol management and related uses |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | CA2461557A1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/23/2003 | CN1413209A 3-(4.5-dihydroisoxazole-5-yl)-benzoylpyrazole |
| 04/22/2003 | US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/22/2003 | CA2117471C Benzisoxazole derivatives and pharmaceutical compositions containing them |
| 04/17/2003 | WO2003031418A1 3,4-dihydro-1h-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/17/2003 | WO2003031404A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2003006454A3 Heterocyclic carboxamides and their use as fungicides |
| 04/17/2003 | US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/17/2003 | US20030073832 Novel aminophenyl ketone derivatives |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 04/16/2003 | EP1301469A1 Preparation of 4-thioalkylbromobenzene derivatives |
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1411373A Novel processes for making-and new crystalline form of-leflunomide |
| 04/15/2003 | US6548677 Halogenating o-xylene; reacting with hydrogen peroxide and halogenating agent to form a benzyl halide; oxidation to aldehyde; oximination, cyclization, and sulfiding |
| 04/10/2003 | WO2003029230A1 Method for preparing benzenesulfonyl compounds |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069267 Modulators of protein tyrosine phosphatases (PTPases) |
| 04/10/2003 | US20030069258 Novel guanidine mimics factor Xa inhibitors |
| 04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
| 04/10/2003 | US20030069225 Synthesis of taxol enhancers |
| 04/09/2003 | EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 04/09/2003 | EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 04/09/2003 | CN1409710A Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles |
| 04/08/2003 | US6545185 Vapor phase oxidation of aldehyde to ketone |
| 04/08/2003 | US6544982 3-aryl-5-aminoisoxazole derivatives |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/03/2003 | WO2002100332A3 Isoxazoline compounds having mif antagonist activity |
| 04/03/2003 | US20030065012 Estrogen receptor modulators |
| 04/03/2003 | US20030064972 Using thiazolidinone compound |
| 04/03/2003 | US20030064429 Generation of picornaviral viricides; prepare chemical intermediates, form ketoester, lyse enolate, acylate, recover viricide |
| 04/03/2003 | US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/02/2003 | EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation |
| 04/02/2003 | EP1296965A1 Method for producing 4-bromine-aniline derivatives |
| 04/02/2003 | EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
| 04/02/2003 | EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 04/02/2003 | CN1406935A Preparation of isoxazolyl ether pyrethrin pesticide |
| 04/02/2003 | CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides |
| 04/02/2003 | CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 04/01/2003 | US6541642 Process for the preparation of (e)-3-(1-propenyl)isoxazoline |
| 04/01/2003 | US6541498 Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| 04/01/2003 | US6541476 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/01/2003 | US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist |
| 04/01/2003 | CA2288439C Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
| 03/27/2003 | WO2003024943A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 03/27/2003 | WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 03/27/2003 | WO2003024920A1 Substituted urea retinoid agonists ii |
| 03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
| 03/27/2003 | CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 03/26/2003 | EP1294679A1 Beta-amino acid nitrile derivatives |
| 03/26/2003 | EP1294366A1 Pharmaceutical compounds for treating copd |